Expression of CIP2A in renal cell carcinomas correlates with tumour invasion, metastasis and patients survival

British Journal of Cancer

Volumn 105, Issue 12, 2011, Pages 1905-1911

  Ren, J ^a   Li, W ^b   Yan, L ^a   Jiao, W ^a   Tian, S ^a   Li, D ^a   Tang, Y ^a   Gu, G ^a   Liu, H ^a   Xu, Z ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

CIP2A; Metastasis; Prognosis; RCC; Survival

Indexed keywords

CANCEROUS INHIBITOR OF PROTEIN PHOSPHATASE 2A; MATRIGEL; MESSENGER RNA; MYC PROTEIN; PHOSPHOPROTEIN PHOSPHATASE 2A; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; AUTOANTIGEN; KIAA1524 PROTEIN, HUMAN; MEMBRANE PROTEIN; PRIMER DNA;

ADULT; ARTICLE; CANCER INVASION; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CANCER TISSUE; CELL ASSAY; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLEAR CELL CARCINOMA; CONTROLLED STUDY; DISEASE SEVERITY; DISTANT METASTASIS; DOWN REGULATION; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; KIDNEY CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; OVERALL SURVIVAL; PAPILLARY CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; GENETICS; KIDNEY TUMOR; METASTASIS; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PATHOLOGY; SURVIVAL; TUMOR CELL LINE; WESTERN BLOTTING;

AUTOANTIGENS; BASE SEQUENCE; BLOTTING, WESTERN; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; DNA PRIMERS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURVIVAL ANALYSIS;

EID: 84856019028     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.492     Document Type: Article

References (36)

1. Basile JR Czerninski R (2010) The role of CIP2A in oral squamous cell carcinoma. Cancer Biol Ther 10: 700-702
2. Baudino TA, McKay C, Pendeville-Samain H, Nilsson JA, Maclean KH, White EL, Davis AC, Ihle JN, Cleveland JL (2002) c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression. Genes Dev 16: 2530-2543
3. Bockelman C, Hagstrom J, Makinen LK, Keski-Santti H, Hayry V, Lundin J, Atula T, Ristimaki A, Haglund C (2011) High CIP2A immunoreactivity is an independent prognostic indicator in early-stage tongue cancer. Br J Cancer 104: 1890-1895
4. Chen KF, Liu CY, Lin YC, Yu HC, Liu TH, Hou DR, Chen PJ, Cheng AL (2010) CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells. Oncogene 29: 6257-6266
5. Choi YA, Park JS, Park MY, Oh KS, Lee MS, Lim JS, Kim KI, Kim KY, Kwon J, Yoon do Y, Moon EY, Yang Y (2011) Increase in CIP2A expression is associated with doxorubicin resistance. FEBS Lett 585: 755-760
6. Cohen HT, McGovern FJ (2005) Renal-cell carcinoma. N Engl J Med 353: 2477-2490 (Pubitemid 41770167)
7. Come C, Laine A, Chanrion M, Edgren H, Mattila E, Liu X, Jonkers J, Ivaska J, Isola J, Darbon JM, Kallioniemi O, Thezenas S, Westermarck J (2009) CIP2A is associated with human breast cancer aggressivity. Clin Cancer Res 15: 5092-5100
8. Dong QZ, Wang Y, Dong XJ, Li ZX, Tang ZP, Cui QZ, Wang EH (2011) CIP2A is overexpressed in non-small cell lung cancer and correlates with poor prognosis. Ann Surg Oncol 18: 857-865
9. Eble JN, Sauter G, Epstein JI, Sesterhenn IA (eds) (2004) World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Urinary Systemandmale Genital Organs. IARC Press: Lyon pp 12-14
10. Fuhrman SA Lasky LC, Limas C (1982) Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6: 655-663 (Pubitemid 13234762)
11. Gordan JD, Bertout JA, Hu CJ, Diehl JA, Simon MC (2007) HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity. Cancer Cell 11: 335-347 (Pubitemid 46518312)
12. Guffei A, Lichtensztejn Z, Goncalves Dos Santos Silva A, Louis SF, Caporali A, Mai S (2007) c-Myc-dependent formation of Robertsonian translocation chromosomes in mouse cells. Neoplasia 9: 578-588 (Pubitemid 47121832)
13. Helland A, Anglesio MS, George J, Cowin PA, Johnstone CN, House CM, Sheppard KE, Etemadmoghadam D, Melnyk N, Rustgi AK, Phillips WA, Johnsen H, Holm R, Kristensen GB, Birrer MJ, Pearson RB, Borresen-Dale AL, Huntsman DG, deFazio A, Creighton CJ, Smyth GK, Bowtell DD (2011) Deregulation of MYCN, LIN28B and LET7 in a molecular subtype of aggressive high-grade serous ovarian cancers. PLoS One 6: e18064
14. Junttila MR Puustinen P, Niemela M, Ahola R, Arnold H, Bottzauw T, Ala-aho R, Nielsen C, Ivaska J, Taya Y, Lu SL, Lin S, Chan EK, Wang XJ, Grenman R, Kast J, Kallunki T, Sears R, Kahari VM, Westermarck J (2007) CIP2A inhibits PP2A in human malignancies. Cell 130: 51-62 (Pubitemid 47039258)
15. Kerosuo L, Fox H, Perala N, Ahlqvist K, Suomalainen A, Westermarck J, Sariola H, Wartiovaara K (2010) CIP2A increases self-renewal and is linked to Myc in neural progenitor cells. Differentiation 80: 68-77
16. Khanna A, Bockelman C, Hemmes A, Junttila MR, Wiksten JP, Lundin M, Junnila S, Murphy DJ, Evan GI, Haglund C, Westermarck J, Ristimaki A (2009) MYC-dependent regulation and prognostic role of CIP2A in gastric cancer. J Natl Cancer Inst 101: 793-805
17. Khew-Goodall Y, Goodall GJ (2010) Myc-modulated miR-9 makes more metastases. Nat Cell Biol 12: 209-211
18. Krieg M, Haas R, Brauch H, Acker T, Flamme I, Plate KH (2000) Upregulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function. Oncogene 19: 5435-5443 (Pubitemid 32000910)
19. Krishnamachary B, Zagzag D, Nagasawa H, Rainey K, Okuyama H, Baek JH, Semenza GL (2006) Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B. Cancer Res 66: 2725-2731
20. Lee J, Park EJ, Hwang JW, Oh JM, Kim H, Bae EK, Choi YL, Han J, Ahn JK, Cha HS, Koh EM (2011) CIP2A expression is associated with synovial hyperplasia and invasive function of fibroblast-like synoviocytes in rheumatoid arthritis. Rheumatol Int; e-pub ahead of print 9 April 2011
21. Li W, Ge Z, Liu C, Liu Z, Bjorkholm M, Jia J, Xu D (2008) CIP2A is overexpressed in gastric cancer and its depletion leads to impaired clonogenicity, senescence, or differentiation of tumor cells. Clin Cancer Res 14: 3722-3728
22. Li W, Zeng J, Li Q, Zhao L, Liu T, Bjorkholm M, Jia J, Xu D (2010) Reptin is required for the transcription of telomerase reverse transcriptase and over-expressed in gastric cancer. Mol Cancer 9: 132
23. Liu J, Wang X, Zhou G, Wang H, Xiang L, Cheng Y, Liu W, Wang Y, Jia J, Zhao W (2011) Cancerous inhibitor of protein phosphatase 2A is overexpressed in cervical cancer and upregulated by human papillomavirus 16 E7 oncoprotein. Gynecol Oncol 122: 430-436
24. Lucas CM, Harris RJ, Giannoudis A, Copland M, Slupsky JR, Clark RE (2011) Cancerous inhibitor of PP2A (CIP2A) at diagnosis of chronic myeloid leukemia is a critical determinant of disease progression. Blood 117: 6660-6668
25. Ma L, Wen ZS, Liu Z, Hu Z, Ma J, Chen XQ, Liu YQ, Pu JX, Xiao WL, Sun HD, Zhou GB (2011) Overexpression and small molecule-triggered downregulation of CIP2A in lung cancer. PLoS One 6: e20159
26. Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D, Teruya-Feldstein J, Reinhardt F, Onder TT, Valastyan S, Westermann F, Speleman F, Vandesompele J, Weinberg RA (2010) miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 12: 247-256
27. Qu W, Li W, Wei L, Xing L, Wang X, Yu J (2010) CIP2A is overexpressed in esophageal squamous cell carcinoma. Med Oncol; e-pub ahead of print 8 December 2010; doi 10.1007/s12032-010-9768-9
28. Smith AP Verrecchia A, Faga G, Doni M, Perna D, Martinato F, Guccione E, Amati B (2009) A positive role for Myc in TGFbeta-induced Snail transcription and epithelial-to-mesenchymal transition. Oncogene 28: 422-430
29. Vaarala MH, Vaisanen MR, Ristimaki A (2010) CIP2A expression is increased in prostate cancer. J Exp Clin Cancer Res 29: 136
30. Vaque JP Fernandez-Garcia B, Garcia-Sanz P, Ferrandiz N, Bretones G, Calvo F, Crespo P, Marin MC, Leon J (2008) c-Myc inhibits Ras-mediated differentiation of pheochromocytoma cells by blocking c-Jun upregulation. Mol Cancer Res 6: 325-339 (Pubitemid 351342420)
31. Viswanathan SR, Powers JT, Einhorn W, Hoshida Y, Ng TL, Toffanin S, O'Sullivan M, Lu J, Phillips LA, Lockhart VL, Shah SP, Tanwar PS, Mermel CH, Beroukhim R, Azam M, Teixeira J, Meyerson M, Hughes TP, Llovet JM, Radich J, Mullighan CG, Golub TR, Sorensen PH, Daley GQ (2009) Lin28 promotes transformation and is associated with advanced human malignancies. Nat Genet 41: 843-848
32. von Rahden BH, Stein HJ, Puhringer-Oppermann F, Sarbia M (2006) c-myc amplification is frequent in esophageal adenocarcinoma and correlated with the upregulation of VEGF-A expression. Neoplasia 8: 702-707 (Pubitemid 44465521)
33. Wang J, Li W, Li L, Yu X, Jia J, Chen C (2011) CIP2A is over-expressed in acute myeloid leukaemia and associated with HL60 cells proliferation and differentiation. Int J Lab Hematol 33: 290-298
34. Wolfer A, Wittner BS, Irimia D, Flavin RJ, Lupien M, Gunawardane RN, Meyer CA, Lightcap ES, Tamayo P, Mesirov JP, Liu XS, Shioda T, Toner M, Loda M, Brown M, Brugge JS, Ramaswamy S (2010) MYC regulation of a 'poor-prognosis' metastatic cancer cell state. Proc Natl Acad Sci USA 107: 3698-3703
35. Zhao D, Liu Z, Ding J, Li W, Sun Y, Yu H, Zhou Y, Zeng J, Chen C, Jia J (2010) Helicobacter pylori CagA upregulation of CIP2A is dependent on the Src and MEK/ERK pathways. J Med Microbiol 59: 259-265
36. Zisman A, Pantuck AJ, Wieder J, Chao DH, Dorey F, Said JW, deKernion JB, Figlin RA, Belldegrun AS (2002) Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. J Clin Oncol 20: 4559-4566 (Pubitemid 35402959)